Gene module analysis of juvenile myelomonocytic leukemia and screening of anticancer drugs

Juvenile myelomonocytic leukemia (JMML) is a rare but severe primary hemopoietic system tumor of childhood, most frequent in children 4 years and younger. There are currently no specific anticancer therapies targeting JMML, and the underlying gene expression changes have not been revealed. To define...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Wencheng, Wang, Lin, Yu, Yongbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196601/
https://www.ncbi.nlm.nih.gov/pubmed/30272300
http://dx.doi.org/10.3892/or.2018.6709

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196601/
https://www.ncbi.nlm.nih.gov/pubmed/30272300
http://dx.doi.org/10.3892/or.2018.6709

Ejemplares similares